| pubmed-article:21604692 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21604692 | lifeskim:mentions | umls-concept:C0023688 | lld:lifeskim |
| pubmed-article:21604692 | lifeskim:mentions | umls-concept:C0599894 | lld:lifeskim |
| pubmed-article:21604692 | lifeskim:mentions | umls-concept:C0085101 | lld:lifeskim |
| pubmed-article:21604692 | lifeskim:mentions | umls-concept:C0185125 | lld:lifeskim |
| pubmed-article:21604692 | lifeskim:mentions | umls-concept:C1521840 | lld:lifeskim |
| pubmed-article:21604692 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:21604692 | pubmed:dateCreated | 2011-6-15 | lld:pubmed |
| pubmed-article:21604692 | pubmed:abstractText | A new bifunctional ligand 3p-C-DEPA was synthesized and evaluated for use in targeted ?-radioimmunotherapy. 3p-C-DEPA was efficiently prepared via regiospecific ring opening of an aziridinium ion and conjugated with trastuzumab. The 3p-C-DEPA-trastuzumab conjugate was extremely rapid in binding (205/6)Bi, and the corresponding (205/6)Bi-3p-C-DEPA-trastuzumab complex was stable in human serum. Biodistribution studies were performed to evaluate in vivo stability and tumor targeting of (205/6)Bi-3p-C-DEPA-trastuzumab conjugate in tumor bearing athymic mice. (205/6)Bi-3p-C-DEPA-trastuzumab conjugate displayed excellent in vivo stability and targeting as evidenced by low organ uptake and high tumor uptake. The results of the in vitro and in vivo studies indicate that 3p-C-DEPA is a promising chelator for radioimmunotherapy of (212)Bi and (213)Bi. | lld:pubmed |
| pubmed-article:21604692 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21604692 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21604692 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21604692 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:21604692 | pubmed:issn | 1520-4812 | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:BrechbielM... | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:MilenicDiane... | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:ChongHyun-Soo... | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:BaidooKwamena... | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:SongHyun AHA | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:ChenYunweiY | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:KangChi SooCS | lld:pubmed |
| pubmed-article:21604692 | pubmed:author | pubmed-author:DaiAnzhiA | lld:pubmed |
| pubmed-article:21604692 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21604692 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:21604692 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:21604692 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21604692 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21604692 | pubmed:pagination | 1128-35 | lld:pubmed |
| pubmed-article:21604692 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:meshHeading | pubmed-meshheading:21604692... | lld:pubmed |
| pubmed-article:21604692 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21604692 | pubmed:articleTitle | Efficient bifunctional decadentate ligand 3p-C-DEPA for targeted ?-radioimmunotherapy applications. | lld:pubmed |
| pubmed-article:21604692 | pubmed:affiliation | Chemistry Division, Biological, Chemical, and Physical Sciences Department, Illinois Institute of Technology, Chicago, Illinois, United States. | lld:pubmed |
| pubmed-article:21604692 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21604692 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21604692 | pubmed:publicationType | Research Support, N.I.H., Extramural | lld:pubmed |
| pubmed-article:21604692 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
